SCHEMBL24672914

SCHEMBL24672914

CCN(CCN(CCNC[C@H](C)O)C[C@H](C)O)Cc1ccc(OC)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.44
NPC1 O15118 1/20 0.44
OPRM1 P35372 1/20 0.41
OPRK1 P41145 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP3A4 P08684 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.39
ADRB2 P07550 3/20 0.38
ADRB3 P13945 2/20 0.37
KDM4E B2RXH2 2/20 0.37
GAA P10253 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ANPEP P15144 1/20 0.36
ERAP2 Q6P179 1/20 0.36
ADRB1 P08588 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24672619 0.83 HDAC8 (0.41) OPRM1OPRK1ADRB3KMT2AADRB1
SCHEMBL24672243 0.83 PYCR1 (0.33) POLBNPC1CYP1A2CYP2D6SMN1; SMN2
SCHEMBL22014453 0.82 OPRK1 (0.38) OPRM1OPRK1SMN1; SMN2KMT2ATSHR
SCHEMBL22014469 0.81 CA2 (0.44) OPRM1OPRK1GAA
SCHEMBL25241112 0.78 POLB (0.48) POLBNPC1SMN1; SMN2HTTTSHR
SCHEMBL25225718 0.78 POLB (0.48) POLBNPC1SMN1; SMN2HTTTSHR
SCHEMBL22014502 0.77 OPRK1 (0.42) POLBOPRM1OPRK1CYP3A4SMN1; SMN2
SCHEMBL22014456 0.76 OPRK1 (0.46) OPRM1OPRK1SMN1; SMN2GAAMAPK1
SCHEMBL22014463 0.76 OPRK1 (0.44) OPRM1OPRK1SMN1; SMN2MAPK1
SCHEMBL22014325 0.76 OPRK1 (0.42) POLBOPRM1OPRK1CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204065-A1 IRON(III) MACROCYCLIC COMPLEXES WITH MIXED HYROXYL PENDANTS AS MRI CONTRAST AGENTS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-09-29 WO disclosed